Physician profile
Stephanie M Allocca
NPI 1700284981
$1,818.83
in general payments reported to CMS, 2019-2025
21 companies · $392 in 2025
The $392 reported for 2025 was more than what 81% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $160 · 2022: $543 · 2023: $425 · 2024: $298 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $368.10 | 2021-2023 | |
| Exeltis, USA INC. | $311.54 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $194.79 | 2022-2025 | |
| Agile Therapeutics, INC. | $173.71 | 2022-2024 | Twirla |
| Evofem Biosciences, INC. | $126.37 | 2021-2024 | |
| Boston Scientific Corporation | $92.37 | 2024-2025 | Watchman Flx |
| Organon LLC | $90.04 | 2022-2025 | Nexplanon |
| Avion Pharmaceuticals | $66.61 | 2022-2023 | Balcoltra |
| Sage Therapeutics, LLC | $65.68 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $58.07 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $53.27 | 2024-2025 | Gardasil 9, Gardasil |
| Millicent US INC | $33.33 | 2025 | Femlyv |
| Sumitomo Pharma America, INC. | $29.39 | 2023 | Myfembree |
| Axonics, INC. | $28.44 | 2023 | Axonics, Bulkamid |
| Coopersurgical, INC. | $26.08 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $24.85 | 2021 | |
| Shield Therapeutics INC | $17.86 | 2024 | |
| Supernus Pharmaceuticals, INC. | $16.89 | 2025 | Qelbree |
| Mylan Pharmaceuticals INC. | $15.56 | 2022 | |
| Therapeuticsmd, INC. | $13.64 | 2022 | |
| Myovant Sciences INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Allocca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.